The Vanderbilt Memory & Alzheimer's Center would like to announce our March lecturer in our VMAC Guest Lecture Series, Dr. Jason Hassenstab.
Dr. Hassenstab is an Assistant Professor of Neurology and of Psychological & Brain Sciences at Washington University in St. Louis. He is the Director of Psychometrics at the Charles F. and Joanne Knight Alzheimer’s Disease Research Center and the Cognition Core Director for the Dominantly Inherited Alzheimer Network (DIAN), and the DIAN-Trials Unit (DIAN-TU), the world’s first Alzheimer’s disease secondary prevention trial. His current research efforts focus on design and validation of cognitive endpoints for clinical trials and detection of early cognitive declines using smartphone technologies in Alzheimer’s disease populations. He is currently funded by the NIH to study the cognitive and brain hemodynamic effects of weight loss on insulin sensitivity in middle-aged individuals at risk for Alzheimer’s disease.
Dr. Hassenstab’s presentation will take place on Tuesday, March 14th in Light Hall Room 208 (at the Vanderbilt University Medical Center) from 8:15-9:15 am.
If you would like to be added to the VMAC Guest Lecture Series Contact List to receive e-mails about upcoming lectures, please click on the link at the bottom of this page.
Vanderbilt University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.